New information collected under the federal Right to Try Act shows promise for the new drug ZYESAMI, now in clinical trials for the treatment of serious cases of COVID-19. The information was collected by a hospital in the U.S. southwest, drug developer NRx announced in a news release Jan. 26. ZYESAMI, developed by the Radnor,
https://www.theepochtimes.com/new-drug-for-seriously-ill-covid-19-patients-shows-promise-under-right-to-try-act_4247983.html

Leave a Reply